Director's Message

Thank you for your interest in the Mood and Anxiety Disorders Program (MAP) at the Icahn School of Medicine at Mount Sinai. MAP is one of the leading centers for the study of Mood Disorders (such as Major Depression and Bipolar Disorder) and anxiety disorders (such as Post-Traumatic Stress Disorder). We focus on treatment-resistant forms of these severe and disabling conditions, which affect a large number of patients in the US and worldwide. The successes of our MAP program in the field of clinical research have not only informed practice, but have also contributed to the development of new standards of care for these difficult-to-treat conditions.

Over the years, MAP has included a large group of experienced researchers as well as promising young trainees and junior faculty, generating a large number of clinical research studies. Our faculty and staff have consistently obtained research funding from the National Institutes of Mental Health, private foundations and industry sources.

Ongoing research studies conducted at MAP include:

  • Trials of cutting-edge treatments for depression, bipolar disorder and PTSD including ketamine, minocycline and other novel antidepressants
  • Psychotherapy studies, including studies of cognitive strategies for the treatment of depression and PTSD
  • Studies of novel somatic therapies, including novel forms of transcranial magnetic stimulation and ECT
  • Non-treatment studies investigating brain function during mood and anxiety disorders with neuroimaging (functional MRI, positron emission tomography and magnetic resonance spectroscopy)

If you would like to learn more about these studies and/or are interested in participating, please read more about our trials. You may also call us at 212-241-7906 or e-mail us at

In addition to carrying out significant research activities, the staff at MAP is involved in delivering excellent clinical care through the Mount Sinai Doctors Faculty Practice at the Icahn School of Medicine. Our clinicians can provide expert consultations and treatment to patients suffering from depression, bipolar disorder and PTSD. If you are interested in scheduling a consultation or ongoing clinical treatment with clinicians in our program, please contact Jazmin Moral at 212-241-0449 or

Dan V. Iosifescu, MD
Director, Mood and Anxiety Disorders Program
Department of Psychiatry, Icahn School of Medicine at Mount Sinai

Contact Us

Tel: 212-241-7906
Fax: 212-241-3354
Send e-mail

Atran Berg Laboratory Building
Floor E Level
1428 Madison Avenue
New York, NY 10029  Map

Participate in Mood and Anxiety Clinical Trials

If you are interested in participating, see our current list of clinical trials for Major Depressive Disorder, Bipolar Disorder, and PTSD.